RESEARCH TRIANGLE PARK, NC – The National Institute of Environmental Health Sciences will invest $13 million to map the DNA of 15 mouse strains important to laboratory research on human health. This initiative, called the "Resequencing Project" will launch the Institute's Center for Rodent Genetics.
The Center for Rodent Genetics is an extension of the Institute's ongoing research to understand the genetic basis for differences in response to drugs and other environmental factors. Other initiatives include the Environmental Genome Project and the National Center for Toxicogenomics.
"The Resquencing Project has attracted world-wide interest and generated a lot of enthusiasm within the research community," said Kenneth Olden, PhD., director of NIEHS, one of the National Institutes of Health. "Because the mouse strains will be sequenced in parallel, inter-strain comparison will begin right away, and their entire genomes will be complete within the next two years."
Mouse strains slated for sequencing include: 129S1/SvImJ, A/J, AKR/J, BALB/cByJ, BTBR T+ tf/J, C3H/HeJ, CAST/EiJ, DBA/2J, FVB/NJ, MOLF/EiJ, KK/HlJ, NOD/LtJ, NZW/LacJ, PWD/PhJ, and WSB/EiJ. Since these strains will be sequenced in reference to C57BL/6J, this project will yield extensive DNA information on a total of 16 strains.
"Knowing the organization of the mouse genome is a key component to identifying which gene-environment interactions are linked to disease in humans," said Dr. William Schrader, Director of the Center. "We'll start by mapping the DNA of 15 strains of mice most often used by researchers to study susceptibility to specific diseases. Then we can determine which diseases develop because of exposure to factors in the environment."
Almost all human genes have counterparts in mice. By examining the environmental triggers of disease in genetically distinct mice, researchers can gain a better understanding of the relationship between genes and the environment in the development of disease in humans. Almost 200 human diseases are affected by exposure to environmental substances. For most diseases, more than one gene is involved and researchers must discover the complex interplay among genes in order to understand how diseases develop.
Examples of diseases targeted for study include: cancer, Parkinson's, Alzheimer's, asthma, and developmental disorders such as autism. Researchers already have identified dozens of genetic components to these disorders, but few well-established animal models are available for understanding the interplay of genes and environment. Therefore, in addition to conducting the Resequencing Project, the Center for Rodent Genetics will build a web-based storehouse of mouse research models accessible to scientists throughout the world.
"The data base will allow scientists to pin-point the models most useful for their own research and will allow them to focus their work on the more likely genetic links to disease," said Dr. Olden. "This will help us identify the causes of disease faster and will make research and drug development more cost effective."
The Resequencing Project, which will be conducted through a 2-year contract with Perlegen Sciences, Inc. of Mountain View, CA, is a foundational effort in a long-term plan. For the first five years, the Center for Rodent Genetics will foster efforts to investigate environmental exposures and disease susceptibility, identify disease mechanisms and pathways, compare mouse and human biomarkers, and encourage development of rapid cell-based methods for comparing the effects of environmental exposures. By the third year, the Center will begin translating research findings to population analysis and to toxicology testing. These studies will also influence the development of curative treatment and regulatory decisions.
"Before genetic mapping, we were able to expose a mouse to environmental toxins and see 'if' a disease developed, but with genetic information, we can also understand 'why' a disease develops," said Olden. "Technology is accelerating both toxicology and environmental health research. NIEHS will lead the way in these two disciplines to make predictions about disease."
The Center for Rodent Genetics will compile the results of genetic research on mice being conducted by several divisions within NIEHS. It also will align with other research initiatives within the National Institutes of Health that use genetically-modified organisms.
"We are not carrying out this work alone. We're coordinating our work to complement other projects, especially the Human Genome Project, which is where we expect to see the most return on our investment," said Dr. Schrader.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
The beauty of balance is that I can do it all and not feel bad about my choices, because every moment is an opportunity to start all over again.